Related Experiment Video
Updated: Aug 2, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Hepatorenal syndrome: Current concepts and future perspectives
Chan-Young Jung1, Jai Won Chang1
1Division of Nephrology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Hepatorenal syndrome (HRS), now called HRS-acute kidney injury (AKI), is a severe kidney complication in advanced cirrhosis. Management involves liver transplantation, vasoconstrictors, albumin, and sometimes kidney replacement therapy.
Area of Science:
- Nephrology
- Hepatology
- Gastroenterology
Background:
- Hepatorenal syndrome (HRS) is a critical complication in advanced cirrhosis, frequently preceding liver transplantation (LT) and leading to mortality.
- Recent advancements have revised the understanding, diagnosis, and classification of HRS, particularly HRS type 1, now termed HRS-acute kidney injury (AKI).
- Pathophysiology involves splanchnic vasodilation, renal vasoconstriction, nitric oxide dysfunction, and systemic inflammation, complicating kidney function in cirrhosis.
Purpose of the Study:
- To provide an updated overview of hepatorenal syndrome (HRS), focusing on its revised nomenclature and diagnostic criteria.
- To discuss the diagnostic challenges, current treatment strategies, and emerging therapies for HRS-AKI.
- To highlight the critical role of liver transplantation as the definitive treatment for HRS-AKI.
Main Methods:
- Review of current literature on hepatorenal syndrome pathophysiology, diagnosis, and management.
- Analysis of revised diagnostic criteria for HRS-AKI.
- Evaluation of treatment modalities including pharmacological interventions, albumin infusion, kidney replacement therapy, and liver transplantation.
Main Results:
- HRS-AKI is characterized by functional kidney impairment without histological abnormalities, posing diagnostic challenges compared to other forms of AKI.
- Treatment involves vasoconstrictors and albumin to improve renal perfusion, with kidney replacement therapy (KRT) as a bridge to transplantation for refractory cases.
- Liver transplantation remains the optimal treatment, while other interventions like TIPS and artificial liver support show limited efficacy.
Conclusions:
- Accurate diagnosis of HRS-AKI is crucial, relying heavily on differential diagnosis due to the absence of specific biomarkers.
- Pharmacological management and KRT can stabilize patients awaiting liver transplantation, which offers the best prognosis.
- Further research is needed to validate novel therapies aimed at improving outcomes for patients with HRS-AKI.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management

